(Q38010552)

26 August 2017

title

Omega 3 fatty acids and inborn errors of metabolism (English)

1 reference

26 August 2017

0 references

Mercedes Gil-Campos

1

1 reference

26 August 2017

Pablo Sanjurjo Crespo

series ordinal

2

1 reference

26 August 2017

language of work or name

1 reference

1 June 2012

1 reference

British Journal of Nutrition

26 August 2017

published in

1 reference

26 August 2017

volume

107 Suppl 2

1 reference

26 August 2017

page(s)

S129-36

1 reference

N-3 fatty acids, cancer and cachexia: a systematic review of the literature

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Nutritional issues in treating phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Omega-3 long-chain polyunsaturated fatty acids in older children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Long term effects of long chain polyunsaturated fats in hyperphenylalaninemic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Essential polyunsaturated fatty acids in plasma and erythrocytes of children with inborn errors of amino acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Age and time trends in fish consumption pattern of children and adolescents, and consequences for the intake of long-chain n-3 polyunsaturated fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Dietary fat intakes for pregnant and lactating women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Cognitive and mood effects of 8 weeks' supplementation with 400 mg or 1000 mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Omega-3 Fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

NORMAL FATTY ACID CONCENTRATIONS IN YOUNG CHILDREN WITH PHENYLKETONURIA (PKU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Fat and fatty acid requirements and recommendations for infants of 0-2 years and children of 2-18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Restoring the DHA levels in the brains of Zellweger patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Early dietary treatments with Lorenzo's oil and docosahexaenoic acid for neurological development in a case with Zellweger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

The Δ4-desaturation pathway for DHA biosynthesis is operative in the human species: Differences between normal controls and children with the Zellweger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Role of the multichannel intraluminal impedance technique in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

A systemic review of the roles of n-3 fatty acids in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Cardiovascular risk factors in vegetarians. Normalization of hyperhomocysteinemia with vitamin B(12) and reduction of platelet aggregation with n-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Classical maple syrup urine disease and brain development: principles of management and formula design

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Early infant diet and the omega 3 fatty acid DHA: effects on resting cardiovascular activity and behavioral development during the first half-year of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

Inborn errors of metabolism with a protein-restricted diet: effect on polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

[Omega 3: is there a situation of deficiency in young children?]

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU).

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

Essential fat requirements of preterm infants

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

Peroxisomal-microsomal communication in unsaturated fatty acid metabolism

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

Essential fatty acids in clinically stable children with propionic acidaemia

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001523

7 January 2021

10.1017/S0007114512001523

Identifiers

DOI

1 reference

26 August 2017

1 reference